Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori

This randomized controlled study aimed to evaluate whether adding bismuth to the standard first-line triple therapy could improve the eradication rate of Helicobacter pylori. A total of 162 patients with Helicobacter pylori infection were randomly assigned to either the 7-day triple therapy group (R...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Meng-Chieh, Wang, Yao-Kuang, Liu, Chung-Jung, Yu, Fang-Jung, Kuo, Fu-Chen, Liu, Min-Li, Kuo, Chao-Hung, Wu, Deng-Chyang, Huang, Yao-Kang, Wu, I-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534286/
https://www.ncbi.nlm.nih.gov/pubmed/28791044
http://dx.doi.org/10.1155/2017/5320180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534286/
https://www.ncbi.nlm.nih.gov/pubmed/28791044
http://dx.doi.org/10.1155/2017/5320180

Ejemplares similares